ask="1.48"
ask_size="200"
average_daily_volume="161181"
bid="1.15"
bid_size="900"
book_value="0.33"
change="-0.02"
change_from_200_day_moving_average="-0.51"
change_from_50_day_moving_average="-0.08"
change_from_52_week_high="-2.29"
change_From_52_week_low="0.38"
change_in_percent="-1.65%"
close="1.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.81"
ebitda="-19.61M"
eps_estimate_current_year="-0.72"
eps_estimate_next_quarter="-0.15"
eps_estimate_next_year="-0.62"
ex_dividend_date="N/A"
float_shares="25247000"
high="1.20"
high_52_weeks="3.48"
last_trade_date="2/28/2017"
last_trade_price="1.19"
last_trade_size="985"
last_trade_time="4:00pm"
low="1.17"
low_52_weeks="0.81"
market_capitalization="30.26M"
moving_average_200_day="1.70"
moving_average_50_day="1.27"
name="Repros Therapeutics Inc."
notes="N/A"
one_year_target_price="5.25"
open="1.19"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="-29.86%"
percent_change_from_50_day_moving_average="-6.13%"
percent_change_from_52_week_high="-65.80%"
percent_change_from_52_week_low="+47.10%"
previous_close="1.21"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.63"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="25425000"
short_ratio="4.86"
stock_exchange="NCM"
symbol="RPRX"
volume="41101"
weeks_range_52="0.81 - 3.48"
